Latest Fonar Corp (FONR) Headlines New Appointm
Post# of 25
Posted On: 03/13/2014 8:40:16 AM
Latest Fonar Corp (FONR) Headlines
New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara
PR Newswire - Wed Mar 05, 6:24AM CST
Today, Analysts Review released its analysts' notes regarding Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), Novavax, Inc. (NASDAQ: NVAX), Fonar Corp. (NASDAQ: FONR), bluebird bio, Inc. (NASDAQ: BLUE), and Cara Therapeutics Inc. (NASDAQ: CARA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Nasdaq stocks posting largest percentage decreases
AP - Wed Feb 19, 5:13PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
4 Stocks Rising on Unusual Volume
at The Street - Tue Feb 18, 5:00AM CST
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Exxon Mobil Leads Blue-Chip Rally; Techs Can't Keep Up
at Investor's Business Daily - Fri Feb 14, 12:18PM CST
Stocks traded quietly -- mixed and mostly unchanged -- just past the midway point of Friday's session. The Dow Jones industrial average rose 0.5%, with Exxon Mobil (XOM), UnitedHealth (UNH) and Procter & Gamble (PG) leading the charge. The S&P 500...
FONAR Announces Fiscal 2014 Second Quarter Earnings Results
Marketwire - Fri Feb 14, 8:31AM CST
FONAR Corporation (NASDAQ: FONR),
Today's Dead Cat Bounce Stock: Fonar Corporation (FONR)
at The Street - Fri Jan 17, 9:58AM CST
Trade-Ideas LLC identified Fonar Corporation (FONR) as a "dead cat bounce" (down big yesterday but up big today) candidate
Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine
PR Newswire - Thu Jan 09, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Medivation, Inc. (NASDAQ: MDVN), Envision Healthcare Holdings, Inc. (NYSE: EVHC), Fonar Corp. (NASDAQ: FONR), Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), and Neurocrine Biosciences Inc. (NASDAQ: NBIX). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
3 Stocks Spiking on Unusual Volume
at The Street - Tue Jan 07, 6:00AM CST
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Napco, Lionbridge: 2 Small-Caps Making Big Moves
at The Street - Fri Dec 13, 5:00AM CST
Some of the best investment calls in 2013 have been among small-mid cap tech and healthcare stocks trading for $5-$10 with medium-term catalysts.
New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara
PR Newswire - Wed Mar 05, 6:24AM CST
Today, Analysts Review released its analysts' notes regarding Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), Novavax, Inc. (NASDAQ: NVAX), Fonar Corp. (NASDAQ: FONR), bluebird bio, Inc. (NASDAQ: BLUE), and Cara Therapeutics Inc. (NASDAQ: CARA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Nasdaq stocks posting largest percentage decreases
AP - Wed Feb 19, 5:13PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
4 Stocks Rising on Unusual Volume
at The Street - Tue Feb 18, 5:00AM CST
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Exxon Mobil Leads Blue-Chip Rally; Techs Can't Keep Up
at Investor's Business Daily - Fri Feb 14, 12:18PM CST
Stocks traded quietly -- mixed and mostly unchanged -- just past the midway point of Friday's session. The Dow Jones industrial average rose 0.5%, with Exxon Mobil (XOM), UnitedHealth (UNH) and Procter & Gamble (PG) leading the charge. The S&P 500...
FONAR Announces Fiscal 2014 Second Quarter Earnings Results
Marketwire - Fri Feb 14, 8:31AM CST
FONAR Corporation (NASDAQ: FONR),
Today's Dead Cat Bounce Stock: Fonar Corporation (FONR)
at The Street - Fri Jan 17, 9:58AM CST
Trade-Ideas LLC identified Fonar Corporation (FONR) as a "dead cat bounce" (down big yesterday but up big today) candidate
Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine
PR Newswire - Thu Jan 09, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Medivation, Inc. (NASDAQ: MDVN), Envision Healthcare Holdings, Inc. (NYSE: EVHC), Fonar Corp. (NASDAQ: FONR), Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), and Neurocrine Biosciences Inc. (NASDAQ: NBIX). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
3 Stocks Spiking on Unusual Volume
at The Street - Tue Jan 07, 6:00AM CST
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Napco, Lionbridge: 2 Small-Caps Making Big Moves
at The Street - Fri Dec 13, 5:00AM CST
Some of the best investment calls in 2013 have been among small-mid cap tech and healthcare stocks trading for $5-$10 with medium-term catalysts.
(0)
(0)